glp 1 agonists reduce inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Mechanisms of action of GLP-1RA.

Also, data analysis showed that the serum GLP-1 level of patients with newly diagnosed T2DM combined with CAS was significantly reduced compared with the control group

If you are trying to lose weight and looking for a long-term solution with a low risk of adverse effects, working 1:1 with a personal dietitian can help

Aslam, M

Lancet Diabetes Endocrinol 2016;4:52536.PubMed 55

At 48 weeks, the mean relative change from baseline in liver fat was 51.3% (1 mg), 59.0% (4 mg), 81.7% (8 mg), 86.0% (12 mg), and 4.6% (placebo)

10.1016/j.cmet.2006.01.004 [DOI] [PubMed] [Google Scholar] 12.Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G, et al